drugset / Trial / NCT03808259

A Study to Investigate the Different Modes of (S) Ketamine Administration in Healthy Participants

NCT03808259

Phase 1 Completed 96 enrolled Janssen Research & Development, LLC
RandomizedSequentialDouble-blindOther

Summary

The purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of different modes of (S) ketamine administration in healthy participants.

Timeline

Start
2018-12-20
Primary completion
2019-09-04
Completion
2019-09-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Esketamine Other / unclassified 7 mg Other
Subject Esketamine Other / unclassified 14 mg Other
Subject Esketamine Other / unclassified 28 mg Other

Indications

No indication recorded.